MedTrace Logo

Prevalence of ESBL and CPE in French Nursing Homes

NCT03401242 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 734

Last updated 2019-04-16

No results posted yet for this study

Summary

CARBEHPAD is a multicentric randomized prevalence study aiming to assess the frequency of Enterobacteriaceae (ESLB) and carbapenemase producing Enterobacteriaceae (CPE) carriage in Pays de la Loire nursing homes.

A sample of 50 nursing homes (NH) in Pays de la Loire will be randomly selected for inclusion, and a sample of 1/3 of residents of these NH will be screened for ESBL and/or CPE fecal carriage. Epidemiological data on each resident will be collected to identify risk factors for such carriage.

Conditions

  • Enterobacteriaceae Infections

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Gabriel BIRGAND, Dr · Nantes University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-03
Primary Completion
2019-01-14
Completion
2019-01-14

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03401242 on ClinicalTrials.gov